A new testing kit has been launched in the UAE for detecting COVID-19 antibodies in people.
It will support the efforts of frontline workers and will also help organisations with the return of their employees to the workplace.
The serology test kits can determine whether individuals have been exposed to the virus and have developed antibodies.
However, they are not meant to replace the traditional RT- PCR testing, and will instead complement its efforts.
The Abu Dhabi-based National Reference Laboratory (NRL), part of Mubadala Healthcare’s network, has announced plans to release the kits to the local market.
While acknowledging that Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) testing remains the gold standard for diagnosing COVID-19, NRL experts are highlighting the benefits of their new serology test kits, stating these complementary antibody tests provide useful information for treating the disease and analyzing its spread, as well as having potential implications for human resource planning.
"While anyone can take these tests to determine whether they have been exposed to the virus and have developed antibodies, it does not mean they can ignore precautions, more studies are needed on the protective nature of the antibodies," said Dr. Laila Abdel Wareth, NRL’s Deputy CEO and Chief Scientific Officer.


UAE President offers condolences to Jordanian King over church attack
UAE launches urgent earthquake relief response for Panama
Ras Al Khaimah closes all beaches 'until further notice'
H.H. Sheikh Hamdan names FIX's popular 'Dubai Chocolate' for Dubai-it award
Abu Dhabi Crown Prince meets Emirati military students in Greece
Young Arab readers to be celebrated on October 29: H.H. Sheikh Mohammed
'Ahmed bin Rashid Humanitarian Bridge' sends another aid aircraft for Gaza
Dubai Police warn jobseekers against fake part-time offers
